FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to (3S,5S)-7-[3-amino-5-methylpiperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-chinoline carboxylic acid malate salts and polymorphs.
EFFECT: invention refers to the pharmaceutical composition containing the described salts and polymorphs which can find application in medicine for treatment or prevention of infectious disorders.
16 cl, 13 dwg, 1 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INTERMEDIATE COMPOUNDS AND METHODS OF OBTAINING 4-(ACETYLAMINO)-3-[(4-CHLOROPHENYL)THIO]-2-METHYL-1H-INDOLE-1-OF ACETIC ACID | 2010 |
|
RU2551852C2 |
| SOLID FORMS (2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZIL)PHENYL)-6-(METHYLTHIO)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL AND METHODS FOR THEIR OBTAINING | 2009 |
|
RU2505543C2 |
| METHOD AND PROCESS OF PREPARATION AND PRODUCTION OF DEUTERATED OMEGA-DIPHENYLUREA | 2011 |
|
RU2527037C2 |
| SYNTHESIS AND NEW SALINE FORMS OF (R)-5-((E)-2-(PYRROLIDIN-3-YLVINYL)PYRIMIDINE | 2009 |
|
RU2533819C2 |
| SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE | 2014 |
|
RU2700796C2 |
| SALT OF OMECAMTIV MECARBIL AND PROCESS FOR PREPARING SAME | 2014 |
|
RU2663663C2 |
| TARTRATE 3-((1R,3R)-1-(2,6-DIFLUORINE-4-((1-(3- FLUOROPROPYL)AZETIDINE-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-b]INDOLE-2-YL)-2,2-DIFLUOROPROPANE-1-OL, ITS SOLID FORMS, METHOD OF ITS PREPARATION AND THEIR APPLICATION | 2019 |
|
RU2809220C2 |
| PROCESS FOR PREPARATION OF N-[(3-AMINOOXETAN-3-YL)METHYL]-2-(1,1-DIOXO-3,5-DIHYDRO-1,4-BENZOTHIAZEPINE-4-YL)-6-METHYL-QUINAZOLINE-4-AMINE | 2015 |
|
RU2664643C2 |
| METHODS OF PRODUCING (3R, 3aS, 6aR) HEXAHYDROFURO[2,3-b]FURAN-3-OL | 2005 |
|
RU2421458C2 |
| METHOD OF PRODUCING (S)-3-HYDROXY-1-(1H-INDOL-5-YL)-2-OXO-PYRROLIDINE-3-CARBOXYLIC ACID 3,5-DIFLUORO-BENZYLAMIDE | 2020 |
|
RU2826010C2 |
